| Cat. No. |
Product Name / Activity |
| 2072 |
Aminopurvalanol A |
| Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5 |
| 3968 |
AZD 5438 |
| Cdk inhibitor; potently inhibits cdk1, 2, 5 and 9 |
| 3194 |
BIO |
| Cdk inhibitor; also potent GSK-3 inhibitor |
| 5654 |
BMS 265246 |
| Cdk inhibitor; potently inhibits cdk1 and cdk2 |
| 5471 |
CGP 60474 |
| Potent cdk inhibitor |
| 3605 |
(R)-CR8 |
| Cdk inhibitor; potently inhibits cdk1 and cdk2; also inhibits CK1; acts as molecular glue |
| 6174 |
CVT 313 |
| Cdk2 and cdk5 inhibitor |
| 3610 |
(R)-DRF053 dihydrochloride |
| Cdk inhibitor; also potent CK1 inhibitor |
| 3094 |
Flavopiridol hydrochloride |
| Cdk inhibitor; potently inhibits cdk2 and cdk9 |
| 1813 |
Indirubin-3'-oxime |
| Cdk inhibitor; also inhibits GSK-3β and other protein kinases |
| 1398 |
Kenpaullone |
| Cdk inhibitor; also inhibits GSK-3β |
| 3140 |
PHA 767491 hydrochloride |
| Cdk inhibitor; potently inhibits cdk9; also inhibits MK2 |
| 1580 |
Purvalanol A |
| Cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5 |
| 1581 |
Purvalanol B |
| Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5 |
| 5494 |
R 547 |
| Potent and selective cdk inhibitor; orally bioavailable |
| 1332 |
Roscovitine |
| Cdk inhibitor |
| 4075 |
SNS 032 |
| Cdk inhibitor; potently inhibits cdk2, cdk7 and cdk9 |